GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma
Y Xue,G Wu,Y Liao,G Xiao,X Ma,X Zou,G Zhang,R Xiao,X Wang,Q Liu,D Long,J Yang,H Xu,F Liu,M Liu,K Xie,R Huang
DOI: https://doi.org/10.1038/bjc.2014.124
IF: 9.075
2014-01-01
British Journal of Cancer
Abstract:Background: Golgi phosphoprotein 3 (GOLPH3) has been reported to be involved in the development of several human cancers. The present study was conducted to investigate the expression of GOLPH3 and its prognostic significance in renal cell carcinoma (RCC). Meanwhile, the function of GOLPH3 in human RCC was further investigated in cell culture models. Methods: Expression of GOLPH3 was examined in 43 fresh RCC tissues and paired adjacent normal renal tissues by real-time quantitative PCR and western blotting. Immunohistochemistry for GOLPH3 was performed on additional 218 RCC tissues. The clinical significance of GOLPH3 expression was analysed. Downregulation of GOLPH3 was performed using small-interfering RNA (siRNA) in Caki-1 and 786-O cells with high abundance of GOLPH3, and the effects of GOLPH3 silencing on cell proliferation, migration, invasion in vitro , and tumour growth in vivo were evaluated. Results: Expression of GOLPH3 was upregulated in the majority of the RCC clinical tissue specimens at both mRNA and protein levels. Clinicopathological analysis showed that GOLPH3 expression was significantly correlated with T stage ( P <0.001), lymph-node status ( P =0.003), distant metastasis ( P <0.001), tumour-node-metastasis (TNM) stage ( P <0.001), and Fuhman grade ( P =0.001). Expression of GOLPH3 was inversely correlated with both overall and recurrence-free survival of RCC patients. Multivariate analysis showed that GOLPH3 expression was an independent prognostic indicator for patient’s survival. Knockdown of the GOLPH3 expression reduced cell proliferation, anchorage-independent growth, migration, invasion, and tumour growth in xenograft model mice. Conclusions: These results suggest that GOLPH3 expression is likely to have important roles in RCC development and progression, and that GOLPH3 is a prognostic biomarker and a promising therapeutic target for RCC.